Oncternal Therapeutics, Inc.
Compounds for treatment of cancer
Last updated:
Abstract:
The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer.
Status:
Grant
Type:
Utility
Filling date:
21 Feb 2019
Issue date:
10 Aug 2021